Tags

Type your tag names separated by a space and hit enter

Vasculitic neuropathy.
Baillieres Clin Neurol 1994; 3(1):193-210BC

Abstract

Patients with vasculitic neuropathy may present with either mononeuritis multiplex, or a symmetrical or asymmetrical sensorimotor neuropathy. In those patients whose neuropathy is part of a systemic vasculitis the neuropathy can be expected to improve leaving only mild or moderate functional disability. Nevertheless, the long-term outlook for such patients is poor with a 5-year survival of around 50% with most excess deaths being due to vascular disease. The prognosis in non-systemic vasculitic neuropathy is almost certainly substantially better than this. Treatment of vasculitic neuropathy should be based on diagnosis by tissue biopsy, usually of nerve, and early use of aggressive immunosuppression.

Authors+Show Affiliations

Department of Neurology, Royal Prince Alfred Hospital, New South Wales, Australia.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

7921589

Citation

Davies, L. "Vasculitic Neuropathy." Bailliere's Clinical Neurology, vol. 3, no. 1, 1994, pp. 193-210.
Davies L. Vasculitic neuropathy. Baillieres Clin Neurol. 1994;3(1):193-210.
Davies, L. (1994). Vasculitic neuropathy. Bailliere's Clinical Neurology, 3(1), pp. 193-210.
Davies L. Vasculitic Neuropathy. Baillieres Clin Neurol. 1994;3(1):193-210. PubMed PMID: 7921589.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vasculitic neuropathy. A1 - Davies,L, PY - 1994/4/1/pubmed PY - 1994/4/1/medline PY - 1994/4/1/entrez SP - 193 EP - 210 JF - Bailliere's clinical neurology JO - Baillieres Clin Neurol VL - 3 IS - 1 N2 - Patients with vasculitic neuropathy may present with either mononeuritis multiplex, or a symmetrical or asymmetrical sensorimotor neuropathy. In those patients whose neuropathy is part of a systemic vasculitis the neuropathy can be expected to improve leaving only mild or moderate functional disability. Nevertheless, the long-term outlook for such patients is poor with a 5-year survival of around 50% with most excess deaths being due to vascular disease. The prognosis in non-systemic vasculitic neuropathy is almost certainly substantially better than this. Treatment of vasculitic neuropathy should be based on diagnosis by tissue biopsy, usually of nerve, and early use of aggressive immunosuppression. SN - 0961-0421 UR - https://www.unboundmedicine.com/medline/citation/7921589/Vasculitic_neuropathy_ L2 - https://medlineplus.gov/vasculitis.html DB - PRIME DP - Unbound Medicine ER -